This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Latest News
Latest News
Norgine Ventures Management Limited, Norgine House, Widewater Place, Moorhall Road, Harefield, Uxbridge, UB9 6NS UK. Norgine Ventures Management Limited is a limited company registered in England and Wales with company number 08723417. NORGINE and the sail logo are trademarks of the Norgine group of companies.
Norgine Ventures Management Limited is authorised and regulated by the Financial Conduct Authority, registration number 917803.
Investing in smaller and unlisted companies (which may be start-up or early stage businesses) involves risks. These risks include possible loss of capital, illiquidity and dilution. Such companies will often not pay dividends. You should not invest in any such company (or any fund that invests in such companies) unless you understand the risks involved, and have taken advice where necessary. A more detailed statement of risks involved can be found here Risk Warning.
Norgine Ventures completes €3 Million Financing With PulseCath
London. 10 October 2016, 09.00 AM BST. Norgine Ventures announced that it has provided financing of up to €3 million to PulseCath B.V.. This investment recognises the unique positioning of PulseCath’s cardiac assist devices and the growth potential of the company. PulseCath, based in the Netherlands, develops and commercialises innovative left ventricle assist devices. The […]
Norgine Ventures completes €5 million Financing with Q3 Medical Devices
London, England, June 21, 2016 – Q3 Medical Devices today announced that it has received financing of up to €5million from Norgine Ventures. This investment recognises the growth prospects of Q3 Medical Devices, an Irish based holding company with multiple operations in Germany focused on the development, manufacturing and distribution of minimally invasive devices for […]
Norgine Ventures Announces Successful Conclusion of its Investment in Stanmore Implants
London. 17 May 2016, 07:00 am BST. Norgine Ventures announced that it has successfully exited its investment in Stanmore Implants Worldwide Limited (SIW) following the acquisition of SIW by Stryker Corporation (“Stryker”) in an all cash transaction for £35.6m. Stanmore Implants is an orthopaedics company focused on the specialist design and manufacture of patient-specific implants […]
Norgine Ventures Announces Successful Conclusion of its Investment in Innovative Pharma Company Internis
London. 12 January 2015, 09.00 AM GMT. Norgine Ventures today announced that it has successfully exited its investment in Internis Pharmaceuticals Limited following the acquisition of Internis by an undisclosed pharmaceutical company in December 2014. This transaction represents a significant achievement for this exciting and innovative British company. Internis, founded in 2010 by Charles Tannenbaum, […]
Norgine Ventures completes €4 million financing with SpineVision SA
London. 3 November 2014, 07:00 AM BST. Norgine Ventures today announced that it has provided financing of €4 million to SpineVision SA. The financing was realised in form of private bonds with warrants. Norgine Ventures is a business entity of Norgine, a European specialist pharmaceutical company. Norgine Ventures’ investment will help SpineVision finance development of […]
Norgine Ventures completes €7 million financing with Azanta Danmark A/S
London. Monday 13 October 2014. 07:00 AM BST. Norgine Ventures today announced that it has provided financing of up to €7million to Azanta Danmark A/S. This investment recognises the growth prospects of Azanta, a specialty pharma company marketing oncology, women’s health and addiction medicine products. The funding will help Azanta finance its late-stage clinical development […]